Governance: The Glue to a Successful Launch
At the core of every successful launch lies a meticulously crafted plan, a robust governance structure, and expert management of its execution. Last…
Your Data Needs a Strategy
In the not-so-distant past, physician prescribing data was essentially a commodity with limited breadth or depth for the purposes of drug…
Success in Rare Disease: Patient Involvement Matters!
This past December, the FDA finalized its guidance on rare diseases with the publication Rare Diseases: Considerations for the…
Juggling Geographic Commercialization Priorities
Commercializing a pharmaceutical asset in one country is hard enough. Doing it on a global scale, with multiple country differences, is…
Medical Affairs: An Orchestra, Not a Horse Race
Every horse race has a starting bell, a push to move as fast as possible, and a finish line. In many ways, the launch of a new drug can feel…
Three Big Mistakes
https://open.spotify.com/show/3CAgqBeNGb8AgRrAbRbKqn?si=44733b0797fe4a12 Over the past 20 years, The NemetzGroup has been involved in the…
The Truth about Teams
When it comes to team performance and adherence to “best practices,” what works on paper or in a teambuilding workshop and what actually occurs are…
Patient Advocacy – Delivering on Patient Centricity in Drug Development
Historically, biopharma companies developed drugs for patients with an illness — but the illness was the primary focus. In recent years, much has…
Beyond the One-Hit Wonder
Innovation in our industry is extraordinary on so many levels. The science is unparalleled, the collective intellect is exceptional, and the passion…
Optimizing Collaboration between Commercial and Medical Affairs
https://open.spotify.com/episode/3GOKLsSOZUazyPRTkrhCju?si=dbc71374cf0641cf&nd=1